Federation Des Caisses Desjardins Du Quebec Arbutus Biopharma Corp Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 800 shares of ABUS stock, worth $2,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800
Previous 800
-0.0%
Holding current value
$2,872
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ABUS
# of Institutions
160Shares Held
99.7MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$77.9 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$46.2 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$41.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$32 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$30.1 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $538M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...